Skip to main content

Home > Releases > Quarterly Financial Report > Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Interest Expense

Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Interest Expense (QFR105385USNO)

Observations

Q1 2026: 7,308
Updated: Jun 8, 2026 9:24 AM CDT
Q1 2026:  7,308  
Q4 2025:  7,598  
Q3 2025:  7,714  
Q2 2025:  8,138  
Q1 2025:  7,724  

Units:

Millions of Dollars,
Not Seasonally Adjusted

Frequency:

Quarterly

Fullscreen

Notes

Title Release Dates
Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Interest Expense 2017-09-06 2026-06-08
 
Source    
U.S. Census Bureau 2017-09-06 2026-06-08
 
Release    
Quarterly Financial Report 2017-09-06 2026-06-08
 
Units    
Millions of Dollars 2017-09-06 2026-06-08
 
Frequency    
Quarterly 2017-09-06 2026-06-08
 
Seasonal Adjustment    
Not Seasonally Adjusted 2017-09-06 2026-06-08
 
Notes    
Further information related to the Quarterly Financial Report survey can be found at https://www.census.gov/econ/qfr/about.html
Methodology details can be found at https://www.census.gov/econ/qfr/documents/QFR_Methodology.pdf

2017-09-06 2026-06-08

Release Tables

Quarterly Financial Report

Related Data and Content

Data Suggestions Based On Your Search

Content Suggestions

Related Categories

Financial Activity Measures Financial Indicators Money, Banking, & Finance

Releases

More Series from Quarterly Financial Report

Tags

Medicines Pharmaceuticals Quarterly Financial Report Chemicals Nondurable Goods Finance Expenditures Corporate Goods Interest Manufacturing Industry Census Quarterly Nation Public Domain: Citation Requested United States of America Not Seasonally Adjusted